Found: 1
Select item for more details and to access through your institution.
Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up.
- Published in:
- European Heart Journal, 2005, v. 26, n. 23, p. 2524, doi. 10.1093/eurheartj/ehi459
- By:
- Publication type:
- Article